Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 2Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Completed 3Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 6FED 1

Study Type

Interventional 6

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 3499Neoplasms 2740Prostatic Neoplasms 1583Colorectal Neoplasms 1248Lung Neoplasms 1188Motor Activity 766Head and Neck Neoplasms 621Pancreatic Neoplasms 601Colonic Neoplasms 586Uterine Cervical Neoplasms 567Carcinoma, Non-Small-Cell Lung 560Carcinoma, Hepatocellular 559Rectal Neoplasms 516Stomach Neoplasms 493Brain Neoplasms 438Anxiety Disorders 401Ovarian Neoplasms 399Pain 376Esophageal Neoplasms 347Polycystic Ovary Syndrome 341Neoplasm Metastasis 340Fatigue 324Urinary Bladder Neoplasms 314Precursor Cell Lymphoblastic Leukemia-Lymphoma 303Melanoma 298Depression 286Multiple Myeloma 283Endometrial Neoplasms 263Lymphoma 258Hematologic Neoplasms 251

Interventions

Hearing Tests 1Dexamethasone 1Cisplatin 1Audiometry 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase NA × OTHER × Ototoxicity × Clear all
NCT06036407 2026-04-14

HEAR

University of Bern

Phase NA Completed
476 enrolled

Ototoxicity, Neoplasms, Hearing Loss

NCT05789316 2026-01-12

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Washington University School of Medicine

Phase NA Completed
55 enrolled
Head & Neck

Ototoxicity, Head and Neck Neoplasms, Hearing Loss

NCT05936034 2025-11-28

PROTOTOX

Institut de Cancérologie de Lorraine

Phase NA Recruiting
52 enrolled

Ototoxicity, Hearing Disorders, Neoplasms

NCT06957132 2025-05-04

RISP-OTOTOX

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Not yet recruiting
500 enrolled

Ototoxicity, Neoplasms

NCT03400709 2018-01-17

Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer

Hospital San Juan de Dios, Santiago

Phase NA Completed
45 enrolled

Ototoxicity

NCT02382068 2017-11-09

Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

Ohio State University Comprehensive Cancer Center

Phase NA Withdrawn

Ototoxicity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡